0001209191-18-005204.txt : 20180124 0001209191-18-005204.hdr.sgml : 20180124 20180124173322 ACCESSION NUMBER: 0001209191-18-005204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180122 FILED AS OF DATE: 20180124 DATE AS OF CHANGE: 20180124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18546151 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-22 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2018-01-22 4 M 0 2427 86.52 A 19061 D Common Stock 2018-01-22 4 S 0 2427 161.52 D 16634 D Common Stock 2018-01-23 4 M 0 1289 91.05 A 17923 D Common Stock 2018-01-23 4 M 0 1719 90.29 A 19642 D Common Stock 2018-01-23 4 S 0 3008 166.05 D 16634 D Common Stock 169 I 401(k) Stock Option (Right to Buy) 86.52 2018-01-22 4 M 0 2427 0.00 D 2027-02-02 Common Stock 2427 10517 D Stock Option (Right to Buy) 91.05 2018-01-23 4 M 0 1289 0.00 D 2026-02-01 Common Stock 1289 11602 D Stock Option (Right to Buy) 90.29 2018-01-23 4 M 0 1719 0.00 D 2026-07-11 Common Stock 1719 8594 D Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 2/3/2017. The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 7/12/2016. /s/ Omar White, Attorney-in-Fact 2018-01-24